Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline) - PubMed (original) (raw)
Clinical Trial
Differential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline)
D L Murphy et al. J Neural Transm Suppl. 1998.
Abstract
Marked, dose-dependent elevations in the urinary excretion of phenylethylamine, para-tyramine, and meta-tyramine were observed in depressed patients treated for three or more weeks with 10, 30, or 60 mg/day of the partially-selective inhibitor of MAO-B, selegiline (l-deprenyl). In comparative studies with other, structurally similar acetylenic inhibitors of MAO, pargyline, an MAO-B > MAO-A inhibitor used in doses of 90 mg/day for three or more weeks, produced elevations in these trace amines which were similar to those found with the highest dose of selegiline studied. Clorgyline, a selective inhibitor of MAO-A used in doses of 30 mg/day for three or more weeks (a dose/time regimen previously reported to reduce urinary, plasma, and cerebrospinal fluid 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG) > 80%, indicating a marked inhibitory effect on MAO-A in humans in vivo) produced negligible changes in trace amine excretion. In comparison to recent studies of individuals lacking the genes for MAO-A, MAO-B, or both MAO-A and MAO-B, the lack of change in trace amine excretion in individuals with a mutation affecting only MAO-A is in agreement with the observed lack of effect of clorgyline in the present study. Selegiline produced larger changes in trace amines--at least at the higher doses studied--than found in individuals lacking the gene for MAO-B, in agreement with other data suggesting a lesser selectivity for MAO-B inhibition when selegiline was given in doses higher than 10 mg/day. Overall, trace amine elevations in individuals receiving the highest dose of deprenyl or receiving pargyline were approximately three to five-fold lower than the elevations observed in individuals lacking the genes for both MAO-A and MAO-B, suggesting that these drug doses yield incomplete inhibition of MAO-A and MAO-B.
Similar articles
- N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
Karoum F. Karoum F. Br J Pharmacol. 1987 Feb;90(2):335-45. doi: 10.1111/j.1476-5381.1987.tb08963.x. Br J Pharmacol. 1987. PMID: 3103805 Free PMC article. - Human plasma melatonin is elevated during treatment with the monoamine oxidase inhibitors clorgyline and tranylcypromine but not deprenyl.
Murphy DL, Tamarkin L, Sunderland T, Garrick NA, Cohen RM. Murphy DL, et al. Psychiatry Res. 1986 Feb;17(2):119-27. doi: 10.1016/0165-1781(86)90067-3. Psychiatry Res. 1986. PMID: 3008207 - Inhibition of MAO-A activity enhances behavioural activity of rats assessed using water maze and open arena tasks.
Barbelivien A, Nyman L, Haapalinna A, Sirviö J. Barbelivien A, et al. Pharmacol Toxicol. 2001 Jun;88(6):304-12. Pharmacol Toxicol. 2001. PMID: 11453370 - The acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J-508: their properties and applications.
Fowler CJ, Oreland L, Callingham BA. Fowler CJ, et al. J Pharm Pharmacol. 1981 Jun;33(6):341-7. doi: 10.1111/j.2042-7158.1981.tb13800.x. J Pharm Pharmacol. 1981. PMID: 6115003 Review. No abstract available. - Selective MAO A and B inhibitors: their mechanism of action and pharmacology.
Finberg JP, Youdim MB. Finberg JP, et al. Neuropharmacology. 1983 Mar;22(3 Spec No):441-6. doi: 10.1016/0028-3908(83)90194-6. Neuropharmacology. 1983. PMID: 6304562 Review.
Cited by
- Antidepressive-Like Property of Dichloromethane Fraction of Pimenta pseudocaryophyllus and Relevance of Monoamine Metabolic Enzymes.
Fajemiroye JO, Martins JL, Ghedini PC, Galdino PM, de Paula JA, Realino de Paula J, Da Rocha FF, Costa EA. Fajemiroye JO, et al. Evid Based Complement Alternat Med. 2013;2013:659391. doi: 10.1155/2013/659391. Epub 2013 Jan 9. Evid Based Complement Alternat Med. 2013. PMID: 23365611 Free PMC article. - Uptake and Metabolization of Serotonin by Granulosa Cells Form a Functional Barrier in the Mouse Ovary.
Alyoshina NM, Tkachenko MD, Malchenko LA, Shmukler YB, Nikishin DA. Alyoshina NM, et al. Int J Mol Sci. 2022 Nov 27;23(23):14828. doi: 10.3390/ijms232314828. Int J Mol Sci. 2022. PMID: 36499156 Free PMC article. - Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions.
Rendić SP, Crouch RD, Guengerich FP. Rendić SP, et al. Arch Toxicol. 2022 Aug;96(8):2145-2246. doi: 10.1007/s00204-022-03304-3. Epub 2022 Jun 1. Arch Toxicol. 2022. PMID: 35648190 Free PMC article. Review. - Cardioprotective Role of Tinospora cordifolia against Trimethylamine-N-Oxide and Glucose Induced Stress in Rat Cardiomyocytes.
Singhal S, Rani V. Singhal S, et al. Cardiovasc Hematol Agents Med Chem. 2024;22(4):475-494. doi: 10.2174/0118715257270512231013064533. Cardiovasc Hematol Agents Med Chem. 2024. PMID: 37907489 - Molecular Insights into SARS-CoV2-Induced Alterations of the Gut/Brain Axis.
Nataf S, Pays L. Nataf S, et al. Int J Mol Sci. 2021 Sep 28;22(19):10440. doi: 10.3390/ijms221910440. Int J Mol Sci. 2021. PMID: 34638785 Free PMC article.